Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C11H23N7.C4H6O6 |
Molecular Weight | 403.4341 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O[C@H]([C@@H](O)C(O)=O)C(O)=O.CCN(CC)C1=NC(=N\C(N1)=N\N)N(CC)CC
InChI
InChIKey=VYNYHQSBWOQQSB-LREBCSMRSA-N
InChI=1S/C11H23N7.C4H6O6/c1-5-17(6-2)10-13-9(16-12)14-11(15-10)18(7-3)8-4;5-1(3(7)8)2(6)4(9)10/h5-8,12H2,1-4H3,(H,13,14,15,16);1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1
Molecular Formula | C4H6O6 |
Molecular Weight | 150.0868 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | C11H23N7 |
Molecular Weight | 253.3472 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Meladrazine is a drug used in urology as an antispasmodic. Meladrazine acts on the central nervous system as a polysynaptic inhibitor. Its usefulness in treating spasticity in patients with multiple sclerosis is well known. As many of these patients have bladder problems, a coincidental beneficial effect on uninhibited bladders has been discovered. Meladrazine caused a high incidence of side effects; therefore, treatment with terodiline separately is recommended for geriatric patients who have severe motor urge incontinence.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:54:40 GMT 2023
by
admin
on
Sat Dec 16 05:54:40 GMT 2023
|
Record UNII |
7F3DYQ3H7H
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
20423-87-4
Created by
admin on Sat Dec 16 05:54:40 GMT 2023 , Edited by admin on Sat Dec 16 05:54:40 GMT 2023
|
PRIMARY | |||
|
7F3DYQ3H7H
Created by
admin on Sat Dec 16 05:54:40 GMT 2023 , Edited by admin on Sat Dec 16 05:54:40 GMT 2023
|
PRIMARY | |||
|
100000086416
Created by
admin on Sat Dec 16 05:54:40 GMT 2023 , Edited by admin on Sat Dec 16 05:54:40 GMT 2023
|
PRIMARY | |||
|
DTXSID20942599
Created by
admin on Sat Dec 16 05:54:40 GMT 2023 , Edited by admin on Sat Dec 16 05:54:40 GMT 2023
|
PRIMARY | |||
|
88532
Created by
admin on Sat Dec 16 05:54:40 GMT 2023 , Edited by admin on Sat Dec 16 05:54:40 GMT 2023
|
PRIMARY | |||
|
SUB03125MIG
Created by
admin on Sat Dec 16 05:54:40 GMT 2023 , Edited by admin on Sat Dec 16 05:54:40 GMT 2023
|
PRIMARY | |||
|
243-808-0
Created by
admin on Sat Dec 16 05:54:40 GMT 2023 , Edited by admin on Sat Dec 16 05:54:40 GMT 2023
|
PRIMARY | |||
|
m238
Created by
admin on Sat Dec 16 05:54:40 GMT 2023 , Edited by admin on Sat Dec 16 05:54:40 GMT 2023
|
PRIMARY | Merck Index | ||
|
C005040
Created by
admin on Sat Dec 16 05:54:40 GMT 2023 , Edited by admin on Sat Dec 16 05:54:40 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |